GFA
8783
Chiome Bioscience
4583
Pixel
2743
Pluszero
5132
Silver Egg Technology
3961
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.23%7.32B | -5.18%1.96B | 2.17%1.75B | 2.78%1.92B | 0.06%1.69B | 3.46%7.34B | 7.27%2.07B | -1.50%1.71B | 8.21%1.87B | -0.65%1.69B |
Cost of revenue | 3.17%3.58B | -5.36%988M | 5.14%859M | 11.45%983M | 3.15%753M | 7.03%3.47B | 14.98%1.04B | 4.48%817M | 3.40%882M | 3.99%730M |
Gross profit | -3.31%3.73B | -5.09%969M | -0.45%887M | -5.05%941M | -2.29%937M | 0.47%3.86B | 0.39%1.02B | -6.41%891M | 13.13%991M | -4.00%959M |
Operating expense | 3.84%2.52B | 1.55%719M | 10.00%572M | 2.79%664M | 2.18%563M | 2.71%2.43B | 2.02%708M | 1.17%520M | 1.89%646M | 6.17%551M |
Operating profit | -15.38%1.22B | -20.13%250M | -15.09%315M | -19.71%277M | -8.33%374M | -3.10%1.44B | -3.10%313M | -15.30%371M | 42.56%345M | -15.00%408M |
Net non-operating interest income (expenses) | -63.64%-18M | -200.00%-9M | -33.33%-4M | 0.00%-3M | 0.00%-2M | 0.00%-11M | 0.00%-3M | 0.00%-3M | 0.00%-3M | 0.00%-2M |
Non-operating interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Non-operating interest expense | 18.18%13M | 33.33%4M | 33.33%4M | 0.00%3M | 0.00%2M | 0.00%11M | 0.00%3M | 0.00%3M | 0.00%3M | 0.00%2M |
Total other finance cost | --5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment income | -70.37%-92M | -112.50%-34M | -61.29%12M | 105.26%1M | -42.00%-71M | -10.20%-54M | 57.89%-16M | 338.46%31M | -575.00%-19M | -2,400.00%-50M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 428.57%37M | -33M | 63M | 250.00%7M | 0 | 131.82%7M | 0 | 0 | 109.09%2M | 5M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -300.00%-16M | -18M | 0 | 0.00%-4M | 6M | 60.00%-4M | 0 | 0 | -4M | 0 |
Less:Other special charges | ---2M | --0 | --0 | --4M | ---6M | ---- | ---- | ---- | ---- | ---- |
Less:Write off | 350.00%18M | --18M | ---- | ---- | ---- | -50.00%4M | --0 | --0 | ---- | ---- |
Other non-operating income (expenses) | -90.00%1M | -100.00%-2M | 1M | 1M | 1M | 10M | -1M | |||
Income before tax | -18.69%1.13B | -48.30%152M | -5.34%390M | -13.44%277M | -14.44%308M | -0.22%1.39B | 6.52%294M | -1.44%412M | 44.80%320M | -24.05%360M |
Income tax | -5.70%397M | 43.48%66M | -17.95%128M | -6.19%106M | -8.49%97M | -12.47%421M | -60.68%46M | 7.59%156M | 91.53%113M | -33.75%106M |
Net income | -24.46%729M | -65.46%86M | 2.35%261M | -17.39%171M | -16.93%211M | 6.39%965M | 57.59%249M | -6.59%255M | 26.99%207M | -18.85%254M |
Net income continuous operations | -24.35%730M | -65.32%86M | 2.34%262M | -17.39%171M | -16.93%211M | 6.28%965M | 55.97%248M | -6.23%256M | 27.78%207M | -19.11%254M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -24.46%729M | -65.46%86M | 2.35%261M | -17.39%171M | -16.93%211M | 6.39%965M | 57.59%249M | -6.59%255M | 26.99%207M | -18.85%254M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -24.46%729M | -65.46%86M | 2.35%261M | -17.39%171M | -16.93%211M | 6.39%965M | 57.59%249M | -6.59%255M | 26.99%207M | -18.85%254M |
Gross dividend payment | ||||||||||
Basic earnings per share | -17.41%38.62 | -60.00%5 | 11.36%13.92 | -9.55%8.9 | -9.40%10.8 | 12.16%46.76 | 69.38%12.5 | -0.95%12.5 | 31.90%9.84 | -16.23%11.92 |
Diluted earnings per share | -17.47%38.4 | -59.97%4.98 | 11.25%13.84 | -9.65%8.89 | -10.32%10.69 | 11.61%46.53 | 69.46%12.44 | -1.43%12.44 | 32.12%9.84 | -16.23%11.92 |
Dividend per share | 16.67%3.5 | 16.67%3.5 | 0 | 0 | 0 | 50.00%3 | 50.00%3 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |